Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

What is the price of life and why doesn't it increase at the rate of inflation?

Ubel PA, Hirth RA, Chernew ME, Fendrick AM.

Arch Intern Med. 2003 Jul 28;163(14):1637-41. Review. No abstract available.

PMID:
12885677
2.

How frequently should patients with type 2 diabetes mellitus be screened for retinopathy?

Murphy C, Newton W.

J Fam Pract. 2000 May;49(5):395-6. No abstract available.

PMID:
10836765
3.

Finding undiagnosed type 2 diabetes: is it worth the effort?

Engelgau MM, Narayan KM.

Eff Clin Pract. 2001 Nov-Dec;4(6):281-3. No abstract available.

PMID:
11769302
5.

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

Javitt JC, Aiello LP, Chiang Y, Ferris FL 3rd, Canner JK, Greenfield S.

Diabetes Care. 1994 Aug;17(8):909-17.

PMID:
7956643
7.

[Screening for diabetic retinopathy].

Sandberg HO.

Tidsskr Nor Laegeforen. 1991 Aug 20;111(19):2431-2. Norwegian.

PMID:
1926082
8.

Using an economic model of diabetes to evaluate prevention and care strategies in Australia.

Colagiuri S, Walker AE.

Health Aff (Millwood). 2008 Jan-Feb;27(1):256-68. doi: 10.1377/hlthaff.27.1.256.

9.
10.

Cost savings associated with detection and treatment of diabetic eye disease.

Javitt JC.

Pharmacoeconomics. 1995;8 Suppl 1:33-9.

PMID:
10159001
11.

[Screening for diabetic retinopathy].

Hartstra WW, Holleman F, Hoekstra JB, Schlingemann RO.

Ned Tijdschr Geneeskd. 2007 Jan 27;151(4):228-33. Review. Dutch.

PMID:
17323877
12.

Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes.

Huo B, Steffen AT, Swan K, Sikes K, Weinzimer SA, Tamborlane WV.

Diabetes Care. 2007 Feb;30(2):362-3. No abstract available.

PMID:
17259509
13.

Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.

Hayashino Y, Shimbo T, Tsujii S, Ishii H, Kondo H, Nakamura T, Nagata-Kobayashi S, Fukui T.

Int J Cardiol. 2007 May 16;118(1):88-96. Epub 2006 Sep 1.

PMID:
16949690
14.

Cost-effectiveness of type 2 diabetes screening: results from recently published studies.

Icks A, Rathmann W, Haastert B, John J, Löwel H, Holle R, Giani G; KORA Study Group..

Gesundheitswesen. 2005 Aug;67 Suppl 1:S167-71.

PMID:
16032536
15.

Cost-effectiveness of alternative methods for diabetic retinopathy screening.

Wareham NJ.

Diabetes Care. 1993 May;16(5):844. No abstract available.

PMID:
8495630
16.

How often should patients with diabetes be screened for retinopathy?

Brown GC, Brown MM, Sharma S.

JAMA. 2000 Jul 26;284(4):438; author reply 439. No abstract available.

PMID:
10904496
17.

Public health focus: prevention of blindness associated with diabetic retinopathy.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 1993 Mar 19;42(10):191-5.

PMID:
8446094
18.

How often should patients with diabetes be screened for retinopathy?

Hoskins HD Jr.

JAMA. 2000 Jul 26;284(4):438-9. No abstract available.

PMID:
10904497
19.
20.

[How Germany manages it's diabetic patients].

Einecke D.

MMW Fortschr Med. 1999 Oct 21;141(42):4-5. German. No abstract available.

PMID:
10912093

Supplemental Content

Support Center